Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government - PubMed (original) (raw)

. 1997 Jul;43(7):1262-79.

Affiliations

• PMID: 9216474

Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government

W W Franke et al. Clin Chem. 1997 Jul.

Abstract

Several classified documents saved after the collapse of the German Democratic Republic (GDR) in 1990 describe the promotion by the government of the use of drugs, notably androgenic steroids, in high-performance sports (doping). Top-secret doctoral theses, scientific reports, progress reports of grants, proceedings from symposia of experts, and reports of physicians and scientists who served as unofficial collaborators for the Ministry for State Security ("Stasi") reveal that from 1966 on, hundreds of physicians and scientists, including top-ranking professors, performed doping research and administered prescription drugs as well as unapproved experimental drug preparations. Several thousand athletes were treated with androgens every year, including minors of each sex. Special emphasis was placed on administering androgens to women and adolescent girls because this practice proved to be particularly effective for sports performance. Damaging side effects were recorded, some of which required surgical or medical intervention. In addition, several prominent scientists and sports physicians of the GDR contributed to the development of methods of drug administration that would evade detection by international doping controls.

PubMed Disclaimer

Similar articles

• [Use of androgenic anabolic steroids before and during the Olympic Games: less but has not died out].
  de Ronde W. de Ronde W. Ned Tijdschr Geneeskd. 2008 Aug 16;152(33):1820-4. Ned Tijdschr Geneeskd. 2008. PMID: 18783159 Review. Dutch.
• The history of the development of anabolic-androgenic steroids.
  Dotson JL, Brown RT. Dotson JL, et al. Pediatr Clin North Am. 2007 Aug;54(4):761-9, xi. doi: 10.1016/j.pcl.2007.04.003. Pediatr Clin North Am. 2007. PMID: 17723875
• Androgenic-anabolic steroids and the Olympic Games.
  Fitch KD. Fitch KD. Asian J Androl. 2008 May;10(3):384-90. doi: 10.1111/j.1745-7262.2008.00377.x. Asian J Androl. 2008. PMID: 18385900 Review.
• Use of doping agents, particularly anabolic steroids, in sports and society.
  Sjöqvist F, Garle M, Rane A. Sjöqvist F, et al. Lancet. 2008 May 31;371(9627):1872-82. doi: 10.1016/S0140-6736(08)60801-6. Lancet. 2008. PMID: 18514731 Review.
• [Hormones, politics and sport in the German Democratic Republic (1949-1989)].
  Vitoria Ortiz M. Vitoria Ortiz M. An R Acad Nac Med (Madr). 2011;128(4):651-77. An R Acad Nac Med (Madr). 2011. PMID: 23350309 Spanish.

Cited by

• Ovarian steroids: the good, the bad, and the signals that raise them.
  Jamnongjit M, Hammes SR. Jamnongjit M, et al. Cell Cycle. 2006 Jun;5(11):1178-83. doi: 10.4161/cc.5.11.2803. Epub 2006 Jun 1. Cell Cycle. 2006. PMID: 16760656 Free PMC article. Review.
• Neuropsychiatric and Behavioral Involvement in AAS Abusers. A Literature Review.
  Bertozzi G, Salerno M, Pomara C, Sessa F. Bertozzi G, et al. Medicina (Kaunas). 2019 Jul 22;55(7):396. doi: 10.3390/medicina55070396. Medicina (Kaunas). 2019. PMID: 31336641 Free PMC article. Review.
• Success in developing regions: world records evolution through a geopolitical prism.
  Guillaume M, Helou NE, Nassif H, Berthelot G, Len S, Thibault V, Tafflet M, Quinquis L, Desgorces F, Hermine O, Toussaint JF. Guillaume M, et al. PLoS One. 2009 Oct 28;4(10):e7573. doi: 10.1371/journal.pone.0007573. PLoS One. 2009. PMID: 19862324 Free PMC article.
• Growth hormone doping: a review.
  Erotokritou-Mulligan I, Holt RI, Sönksen PH. Erotokritou-Mulligan I, et al. Open Access J Sports Med. 2011 Jul 27;2:99-111. doi: 10.2147/OAJSM.S11626. Open Access J Sports Med. 2011. PMID: 24198576 Free PMC article. Review.
• Cardiorespiratory Fitness in Young Adult Women With a History of Premature Adrenarche.
  Tennilä J, Jääskeläinen J, Utriainen P, Voutilainen R, Laitinen T, Liimatta J. Tennilä J, et al. J Endocr Soc. 2023 Mar 28;7(5):bvad041. doi: 10.1210/jendso/bvad041. eCollection 2023 Mar 6. J Endocr Soc. 2023. PMID: 37077523 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information